Literature DB >> 28024865

Taxonomy for colorectal cancer screening promotion: Lessons from recent randomized controlled trials.

Paul Ritvo1, Ronald E Myers2, Mardie Serenity3, Samir Gupta4, John M Inadomi5, Beverly B Green6, Anthony Jerant7, Jill Tinmouth8, Lawrence Paszat9, Meysam Pirbaglou10, Linda Rabeneck11.   

Abstract

OBJECTIVE: To derive a taxonomy for colorectal cancer screening that advances Randomized Controlled Trials (RCTs) and screening uptake.
DESIGN: Detailed publication review, multiple interviews with principal investigators (PIs) and collaboration with PIs as co-authors produced a CRCS intervention taxonomy. Semi-structured interview questions with PIs (Drs. Inadomi, Myers, Green, Gupta, Jerant and Ritvo) yielded details about trial conduct. Interview comparisons led to an iterative process informing serial interviews until a consensus was obtained on final taxonomy structure.
RESULTS: These taxonomy headings (Engagement Sponsor, Population Targeted, Alternative Screening Tests, Delivery Methods, and Support for Test Performance (EPADS)) were used to compare studies. Exemplary insights emphasized: 1) direct test delivery to patients; 2) linguistic-ethnic matching of staff to minority subjects; and 3) authorization of navigators to schedule or refer for colonoscopies and/or distribute stool blood tests during screening promotion.
CONCLUSION: PIs of key RCTs (2012-2015) derived a CRCS taxonomy useful in detailed examination of CRCS promotion and design of future RCTs.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer prevention; Clinical trials; Colorectal cancer; Colorectal cancer screening; Health service research

Mesh:

Year:  2016        PMID: 28024865     DOI: 10.1016/j.ypmed.2016.12.024

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  3 in total

Review 1.  A systematic review of clinic and community intervention to increase fecal testing for colorectal cancer in rural and low-income populations in the United States - How, what and when?

Authors:  Melinda M Davis; Michele Freeman; Jackilen Shannon; Gloria D Coronado; Kurt C Stange; Jeanne-Marie Guise; Stephanie B Wheeler; David I Buckley
Journal:  BMC Cancer       Date:  2018-01-06       Impact factor: 4.430

2.  Integrated Bioinformatics Analysis of the Hub Genes Involved in Irinotecan Resistance in Colorectal Cancer.

Authors:  Jakub Kryczka; Joanna Boncela
Journal:  Biomedicines       Date:  2022-07-16

Review 3.  A learning community approach to identifying interventions in health systems to reduce colorectal cancer screening disparities.

Authors:  Lillian C Man; Melissa DiCarlo; Emily Lambert; Randa Sifri; Martha Romney; Linda Fleisher; Ronald Myers
Journal:  Prev Med Rep       Date:  2018-10-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.